The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | Common | 00461U105 | 3,607 | 1,647,214 | SH | SOLE | 1,647,214 | 0 | 0 | ||
Agile Therapeutics, Inc. | Common | 00847L100 | 2,210 | 1,513,975 | SH | SOLE | 1,513,975 | 0 | 0 | ||
Akari Therapeutics Plc | ADR | 00972G108 | 699 | 345,850 | SH | SOLE | 345,850 | 0 | 0 | ||
Amyris, Inc | Common | 03236M200 | 23,106 | 6,490,557 | SH | SOLE | 6,490,557 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 9,719 | 383,538 | SH | SOLE | 383,538 | 0 | 0 | ||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 73,277 | 2,765,153 | SH | SOLE | 2,765,153 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 237,225 | 2,060,135 | SH | SOLE | 2,060,135 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 12,592 | 1,913,623 | SH | SOLE | 1,913,623 | 0 | 0 | ||
BioPharmX Corporation | Common | 09072X309 | 189 | 317,270 | SH | SOLE | 317,270 | 0 | 0 | ||
Chiasma Inc | Common | 16706W102 | 17,758 | 2,377,213 | SH | SOLE | 2,377,213 | 0 | 0 | ||
Codexis, Inc | Common | 192005106 | 48,184 | 2,614,458 | SH | SOLE | 2,614,458 | 0 | 0 | ||
Crinetics Pharmaceuticals Inc | Common | 22663K107 | 84,379 | 3,375,169 | SH | SOLE | 3,375,169 | 0 | 0 | ||
Cymabay Therapeutics Inc | Common | 23257D103 | 15,429 | 2,154,934 | SH | SOLE | 2,154,934 | 0 | 0 | ||
DBV Technologies S.A. | ADR | 23306J101 | 2,219 | 269,995 | SH | SOLE | 269,995 | 0 | 0 | ||
Dermira Inc | Common | 24983L104 | 6,692 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Eiger BioPharmaceuticals Inc | Common | 28249U105 | 18,987 | 1,791,257 | SH | SOLE | 1,791,257 | 0 | 0 | ||
Galmed Pharmaceuticals Ltd | SHS | M47238106 | 7,139 | 971,337 | SH | SOLE | 971,337 | 0 | 0 | ||
Genocea Biosciences Inc | Common | 372427401 | 2,455 | 626,401 | SH | SOLE | 626,401 | 0 | 0 | ||
Homology Medicines, Inc. | Common | 438083107 | 22,696 | 1,159,742 | SH | SOLE | 1,159,742 | 0 | 0 | ||
Insmed Inc | Common Par | 457669307 | 44,753 | 1,748,174 | SH | SOLE | 1,748,174 | 0 | 0 | ||
Iovance Biotherapeutics, Inc. | Common | 462260100 | 39,232 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
Kadmon Holdings Inc | Common | 48283N106 | 25,970 | 12,606,605 | SH | SOLE | 12,606,605 | 0 | 0 | ||
Kala Pharmaceuticals, Inc. | Common | 483119103 | 6,654 | 1,043,020 | SH | SOLE | 1,043,020 | 0 | 0 | ||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 30,105 | 1,359,149 | SH | SOLE | 1,359,149 | 0 | 0 | ||
Karuna Therapeutics Inc | Common | 48576A100 | 6,507 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
Kiniksa Pharmaceuticals | Common | G5269C101 | 11,421 | 843,478 | SH | SOLE | 843,478 | 0 | 0 | ||
Matinas Biopharma Hldgs Inc | Common | 576810105 | 5,840 | 6,818,181 | SH | SOLE | 6,818,181 | 0 | 0 | ||
MEI Pharma Inc | Common | 55279B202 | 14,203 | 5,681,397 | SH | SOLE | 5,681,397 | 0 | 0 | ||
Menlo Therapeutics Inc. | Common | 586858102 | 24,027 | 4,011,236 | SH | SOLE | 4,011,236 | 0 | 0 | ||
Mirati Therapeutics Inc. | Common | 60468T105 | 24,004 | 233,045 | SH | SOLE | 233,045 | 0 | 0 | ||
Nabriva Therapeutics AG | SHS | G63637105 | 9,815 | 4,039,139 | SH | SOLE | 4,039,139 | 0 | 0 | ||
Obseva SA | Common | H5861P103 | 10,599 | 937,147 | SH | SOLE | 937,147 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 18,356 | 1,312,084 | SH | SOLE | 1,312,084 | 0 | 0 | ||
Precision Biosciences Inc | Common | 74019P108 | 3,717 | 280,511 | SH | SOLE | 280,511 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | Common | 77313F106 | 11,801 | 786,712 | SH | SOLE | 786,712 | 0 | 0 | ||
Selecta Biosciences Inc | Common | 816212104 | 977 | 546,054 | SH | SOLE | 546,054 | 0 | 0 | ||
Sierra Oncology, Inc | Common | 82640U107 | 1,365 | 2,438,270 | SH | SOLE | 2,438,270 | 0 | 0 | ||
Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
Soleno Therapeutics, Inc. | Common | 834203200 | 11,953 | 4,268,959 | SH | SOLE | 4,268,959 | 0 | 0 | ||
Soleno Therapeutics, Inc. - Warrant | Warrant | 834203135 | 19 | 188,772 | SH | SOLE | 188,772 | 0 | 0 | ||
The Medicines Company | Common | 584688105 | 24,399 | 669,012 | SH | SOLE | 669,012 | 0 | 0 | ||
Tricida, Inc. | Common | 89610F101 | 56,212 | 1,424,525 | SH | SOLE | 1,424,525 | 0 | 0 | ||
Verona Pharma PLC | ADS | 925050106 | 7,614 | 1,492,951 | SH | SOLE | 1,492,951 | 0 | 0 | ||
Xenon Pharmaceuticals Inc | Common | 98420N105 | 13,858 | 1,405,476 | SH | SOLE | 1,405,476 | 0 | 0 | ||
Zogenix Inc | Common | 98978L204 | 5,017 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
Zymeworks Inc | Common | 98985W102 | 31,976 | 1,453,467 | SH | SOLE | 1,453,467 | 0 | 0 |